US regulator greenlights AstraZeneca's blood pressure drug Baxfendy
(Alliance News) - AstraZeneca PLC on Monday reported US clearance for its hypertension treatment Baxfendy. Read More
| Price | 13,892.00p on 20-05-2026 at 10:18:29 |
|---|---|
| Change | 12.00p 0.09% |
| Buy | 13,894.00p |
| Sell | 13,892.00p |
| Last Trade: | Buy 70.00 at 13,894.00p |
| Day's Volume: | 183,850 |
| Last Close: | 13,880.00p |
| Open: | 13,780.00p |
| ISIN: | GB0009895292 |
| Day's Range | 13,762.00p - 13,902.00p |
| 52wk Range: | 10,104.00p - 15,730.00p |
| Market Capitalisation: | £215.44b |
| VWAP: | 13,804.54731p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 70 | 13,894.00p | SI Trade |
11:18:29 - 20-May-26 |
| Sell* | 26 | 13,892.00p | Automatic Execution |
11:18:29 - 20-May-26 |
| Sell* | 1 | 13,892.00p | Automatic Execution |
11:18:29 - 20-May-26 |
| Sell* | 20 | 13,894.00p | Automatic Execution |
11:18:29 - 20-May-26 |
| Sell* | 21 | 13,896.00p | Automatic Execution |
11:18:28 - 20-May-26 |
| Unknown* | 0 | 13,898.00p | SI Trade |
11:18:26 - 20-May-26 |
| Buy* | 20 | 13,898.00p | Automatic Execution |
11:18:24 - 20-May-26 |
| Buy* | 11 | 13,898.00p | Automatic Execution |
11:18:24 - 20-May-26 |
| Buy* | 18 | 13,898.00p | Automatic Execution |
11:18:24 - 20-May-26 |
| Unknown* | 0 | 13,898.00p | SI Trade |
11:18:15 - 20-May-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th May 2026 3:00 pm | RNS | Director/PDMR Shareholding |
| 18th May 2026 7:05 am | RNS | Enhertu approved in two HER2+ early BC settings |
| 18th May 2026 7:00 am | RNS | Baxfendy approved in the US for hypertension |
| 14th May 2026 7:00 am | RNS | Imfinzi + EV improves EFS & OS in bladder cancer |
| 1st May 2026 3:00 pm | RNS | Total Voting Rights and Admission of Shares |
| 1st May 2026 7:05 am | RNS | FDA ODAC vote on camizestrant in breast cancer |
| 1st May 2026 7:00 am | RNS | FDA ODAC recommends Truqap in prostate cancer |
| 29th Apr 2026 7:00 am | RNS | 1st Quarter Results |
| 28th Apr 2026 7:00 am | RNS | Breztri approved in the US for asthma |
| 27th Apr 2026 7:00 am | RNS | Saphnelo self-administration approved in the US |